封面
市场调查报告书
商品编码
1578302

全球萎缩性疤痕治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Atrophic Scar Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

全球萎缩性疤痕治疗市场需求预计将从 2023 年的 270.2 亿美元达到 2032 年近 615.6 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 9.58%。

萎缩性疤痕是由于严重痤疮、水痘或去除痣而在皮肤上形成的疤痕。这些疤痕的形成是因为儘管皮肤下面癒合了,但皮肤无法再生组织。萎缩性疤痕治疗用于减少疤痕的出现。这些疤痕会对生活品质产生重大影响,但对皮肤科医生来说是一个治疗挑战。根据疤痕的形态,采用化学换肤、磨皮、雷射治疗、针刺、干细胞治疗等多种治疗技术。在最坏的情况下,选择各种治疗方法的组合来进行有效的治疗。这些技术也用于治疗交通事故、烧伤和皮肤再生造成的疤痕。

市场动态

由于皮肤病的增加,萎缩性疤痕治疗的市场正在飙升。对抗老化治疗的需求、个人护理费用的激增、医疗保健领域费用的增加、公司提供的报销改善将推动该市场的成长。对治疗替代方案和创新的认识的提高是推动萎缩性疤痕治疗市场的其他因素。 COVID-19 对萎缩性疤痕治疗技术的影响很小,因为病毒似乎对感染者的皮肤没有任何影响。市场面临的主要挑战是治疗萎缩性疤痕的高成本。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球萎缩性疤痕治疗市场的每个细分市场进行了包容性评估。萎缩性疤痕治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

萎缩性疤痕治疗市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按配销通路

  • 药局和药局
  • 医院
  • 电子商务
  • 诊所和皮肤科中心

依产品类型

  • 雷射
  • 专题
  • 可注射
  • 表面处理

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲萎缩性疤痕治疗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。萎缩性疤痕治疗市场的主要参与者包括艾尔建(AbbVie)、Galderma、Merz Pharma、Cynosure、Syneron Candela、Lumenis、Cutera、Sciton、Alma Lasers、Sinclair Pharma、Suneva Medical、强生、Bausch Health Companies、Revance Therapeutics 、远藤国际、赛诺菲、雀巢皮肤健康。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:萎缩性疤痕治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析:按产品类型
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球萎缩性疤痕治疗市场分析:按分销管道

  • 配销通路概览
  • 按配销通路进行历史和预测资料分析
  • 药局和药局
  • 医院
  • 电子商务
  • 诊所和皮肤科中心

第 6 章:全球萎缩性疤痕治疗市场分析:依产品类型

  • 概述:按产品类型
  • 历史与预测资料分析:按产品类型
  • 雷射
  • 专题
  • 可注射
  • 表面处理

第 7 章:全球萎缩性疤痕治疗市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:萎缩性疤痕治疗公司的竞争格局

  • 萎缩性疤痕治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Allergan (AbbVie)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Galderma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merz Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cynosure
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Syneron Candela
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Lumenis
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cutera
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sciton
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Alma Lasers
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sinclair Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Suneva Medical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Johnson & Johnson
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bausch Health Companies
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Revance Therapeutics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Endo International
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Nestle Skin Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11211987

The global demand for Atrophic Scar Treatment Market is presumed to reach the market size of nearly USD 61.56 Billion by 2032 from USD 27.02 Billion in 2023 with a CAGR of 9.58% under the study period 2024-2032.

Atrophic scars are scars formed on the skin due to severe acne, chicken pox or mole removal. These scars are formed because though healed beneath, the skin is unable to regenerate tissue. Atrophic scar treatment is used to reduce the appearance of scars. These scars can have significant impact on the quality of life but is a therapeutic challenge for dermatologists. Based on the morphology of scars various treatment techniques like chemical peeling, dermabrasion, laser treatment, needling, stem cell therapy, etc are used. In worst-case scenarios, a combination of various treatment is chosen for effective treatment. These techniques are also used to treat scars caused by road accidents, burn injuries and skin rejuvenation.

MARKET DYNAMICS

The market for atrophic scar treatment is soaring high due to the increase in skin disorders. Demand for age-defying treatment therapies, surge in expenses on personal care, increased expenses in the area of health care, improved reimbursements offered by firms will propel the growth of this market. Increased awareness of treatment alternatives and innovations are other factors that will boost the market for atrophic scar treatment. The impact of COVID-19 on the atrophic scar treatment techniques is minimal since the virus does not seem to have any effect on the skin of the infected. The main challenge faced by this market is the high costs involved in the treatment of atrophic scars.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Atrophic Scar Treatment. The growth and trends of Atrophic Scar Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Atrophic Scar Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Distribution Channel

  • Pharmacies & Drug Stores
  • Hospitals
  • E-Commerce
  • Clinics & Dermatology Centers

By Product Type

  • Laser
  • Topical
  • Injectable
  • Surface Treatment

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Atrophic Scar Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Atrophic Scar Treatment market include Allergan (AbbVie), Galderma, Merz Pharma, Cynosure, Syneron Candela, Lumenis, Cutera, Sciton, Alma Lasers, Sinclair Pharma, Suneva Medical, Johnson & Johnson, Bausch Health Companies, Revance Therapeutics, Endo International, Sanofi, Nestle Skin Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ATROPHIC SCAR TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Distribution Channel
    • 3.7.2 Market Attractiveness Analysis By Product Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ATROPHIC SCAR TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 5.1. Overview By Distribution Channel
  • 5.2. Historical and Forecast Data Analysis By Distribution Channel
  • 5.3. Pharmacies & Drug Stores Historic and Forecast Sales By Regions
  • 5.4. Hospitals Historic and Forecast Sales By Regions
  • 5.5. E-Commerce Historic and Forecast Sales By Regions
  • 5.6. Clinics & Dermatology Centers Historic and Forecast Sales By Regions

6. GLOBAL ATROPHIC SCAR TREATMENT MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1. Overview By Product Type
  • 6.2. Historical and Forecast Data Analysis By Product Type
  • 6.3. Laser Historic and Forecast Sales By Regions
  • 6.4. Topical Historic and Forecast Sales By Regions
  • 6.5. Injectable Historic and Forecast Sales By Regions
  • 6.6. Surface Treatment Historic and Forecast Sales By Regions

7. GLOBAL ATROPHIC SCAR TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ATROPHIC SCAR TREATMENT COMPANIES

  • 8.1. Atrophic Scar Treatment Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF ATROPHIC SCAR TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Allergan (AbbVie)
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Galderma
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Merz Pharma
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Cynosure
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Syneron Candela
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Lumenis
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Cutera
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Sciton
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Alma Lasers
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Sinclair Pharma
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Suneva Medical
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Johnson & Johnson
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Bausch Health Companies
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Revance Therapeutics
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Endo International
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Sanofi
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments
  • 9.19. Nestle Skin Health
    • 9.19.1 Company Overview
    • 9.19.2 Company Revenue
    • 9.19.3 Products
    • 9.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Distribution Channel (USD MN)
  • Pharmacies & Drug Stores Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Clinics & Dermatology Centers Market Sales By Geography (USD MN)
  • Analysis By Product Type (USD MN)
  • Laser Market Sales By Geography (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Surface Treatment Market Sales By Geography (USD MN)
  • Global Atrophic Scar Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Atrophic Scar Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Atrophic Scar Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Distribution Channel (USD MN)
  • Pharmacies & Drug Stores Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Clinics & Dermatology Centers Market Sales By Geography (USD MN)
  • Global Market Analysis By Product Type (USD MN)
  • Laser Market Sales By Geography (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Surface Treatment Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.